<?xml version="1.0" encoding="UTF-8"?>
<TEI xml:space="preserve" xmlns="http://www.tei-c.org/ns/1.0" 
xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" 
xsi:schemaLocation="http://www.tei-c.org/ns/1.0 https://raw.githubusercontent.com/kermitt2/grobid/master/grobid-home/schemas/xsd/Grobid.xsd"
 xmlns:xlink="http://www.w3.org/1999/xlink">
	<teiHeader xml:lang="en">
		<fileDesc>
			<titleStmt>
				<title level="a" type="main">Experiment title: Structural studies on cell-cycle proteins in complex with small molecule inhibitors</title>
			</titleStmt>
			<publicationStmt>
				<publisher/>
				<availability  status="unknown">
					<licence/>
				</availability>
				<date type="published" when="2000-08-23">23 August, 2000</date>
			</publicationStmt>
			<sourceDesc>
				<biblStruct>
					<analytic>
						<author>
							<persName><surname>Id14-Eh3</surname></persName>
						</author>
						<author>
							<persName><roleName>Dr</roleName><forename type="first">E</forename><surname>Mitchell</surname></persName>
						</author>
						<author>
							<persName><roleName>Dr</roleName><forename type="first">Martin</forename><surname>Noble</surname></persName>
						</author>
						<author>
							<persName><roleName>Dr</roleName><forename type="first">Jane</forename><surname>Endicott</surname></persName>
						</author>
						<author>
							<persName><forename type="first">Louise</forename><surname>Johnson</surname></persName>
						</author>
						<author>
							<affiliation key="aff0">
								<orgName type="laboratory">Laboratory of Molecular</orgName>
								<address>
									<addrLine>Biophysics Rex Richards Building South Parks Road Oxford</addrLine>
									<postCode>OX1 3QU</postCode>
									<country key="GB">U.K</country>
								</address>
							</affiliation>
						</author>
						<author>
							<affiliation key="aff1">
								<orgName type="laboratory">(In collaboration with Dr. M. Legraverend</orgName>
								<orgName type="institution">Centre Universitaire</orgName>
								<address>
									<postCode>91405</postCode>
									<settlement>Orsay Cedex</settlement>
									<country key="FR">France</country>
								</address>
							</affiliation>
						</author>
						<title level="a" type="main">Experiment title: Structural studies on cell-cycle proteins in complex with small molecule inhibitors</title>
					</analytic>
					<monogr>
						<imprint>
							<date type="published" when="2000-08-23">23 August, 2000</date>
						</imprint>
					</monogr>
					<idno type="MD5">AE5F137A227DA082D1444A5B97810BFC</idno>
				</biblStruct>
			</sourceDesc>
		</fileDesc>
		<encodingDesc>
			<appInfo>
				<application version="0.8.2" ident="GROBID" when="2025-05-22T16:08+0000">
					<desc>GROBID - A machine learning software for extracting information from scholarly documents</desc>
					<label type="revision">unknown</label>
					<label type="parameters">startPage=-1, endPage=-1, consolidateCitations=1, consolidateHeader=1, consolidateFunders=0, includeRawAffiliations=false, includeRawCitations=true, includeRawCopyrights=false, generateTeiIds=false, generateTeiCoordinates=[], flavor=null</label>
					<ref target="https://github.com/kermitt2/grobid"/>
				</application>
			</appInfo>
		</encodingDesc>
		<profileDesc>
			<textClass>
				<keywords>LS-1382</keywords>
			</textClass>
			<abstract>
<div xmlns="http://www.tei-c.org/ns/1.0"><head>Cyclin-dependent kinase inhibition by New C-2 Alkynylated Purine Derivatives and Molecular Structure of a CDK2-Inhibitor complex</head><p>A new series of 2,6,9-trisubstitued purines, characterized by the presence of a common alkynyl substituent at C-2 and a range of different anilino/benzylamino groups at C-6, were synthesized. These compounds were evaluated for their capacity to inhibit cyclin-dependent kinase activity (CDK1-cyclin B) in vitro. Compounds 4e and 5e (Table <ref type="table">1</ref>) exhibited the strongest inhibitory actvity with an IC 50 of 60 nM. The structure of compound 4b (OL567) in complex with human CDK2 was determined by X-ray crystallography, revealing the molecular basis of inhibition by this molecule. Data collection and refinement statistics are given in Table <ref type="table">2</ref>. A Ligplot diagram summarizing the interactions between inhibitor and CDK2 is shown in Figure <ref type="figure">1</ref>. Subsequent molecular modelling studies allowed us to rationalize the SAR observed for these compounds.</p></div>
			</abstract>
		</profileDesc>
	</teiHeader>
	<text xml:lang="en">
		<body>
<div xmlns="http://www.tei-c.org/ns/1.0"><p>Table 1 IC 50 values against CDK1-Cyclin B Table 2 Data collection statistics for OL567</p></div>		</body>
		<back>
			<div type="references">

				<listBibl/>
			</div>
		</back>
	</text>
</TEI>
